Clinical studies show allulose can increase postprandial GLP-1 by roughly 2030% above fasting levels in some people, a fraction of the effect achieved by semaglutide
The difference lies not in the goal but in how the active ingredient gets from the product into your bloodstream
Lucas KJ, Lopez P, Lawitz E et al (2020) Tropifexor, a highly potent FXR agonist, produces robust and dose-dependent reductions in hepatic fat and serum alanine aminotransferase in patients with fibrotic NASH after 12 weeks of therapy: FLIGHT-FXR Part C interim results
In these cases, flushing the vial with an inert gas like nitrogen or argon before sealing can help extend the shelf life
A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 Diabetes (SURPASS J-mono)
Cabe destacar que, como en todo medicamento, es fundamental la administracin bajo prescripcin mdica precisa y respetar la dosificacin indicada por el mdico a cargo del tratamiento